Search

September 2019 Latest Research Non-invasive biomarker for assessing adequacy of treatment and predicting relapse in patients treated for pulmonary tuberculosis.

13 Sep 2019 - 22:45

Professor Mark Hatherill has co-authored a journal article titled ""FDG-PET/CT as a Non-invasive biomarker for assessing adequacy of treatment and predicting relapse in patients treated for pulmonary tuberculosis" appearing in the Journal of Nuclear Medicine.

To view abstract. Click here.